GPT and Hepatic fibrosis: However, the experiments showed that treatment with BJRG (600 mg/kg) and CPhGs (125, 250, and 500 mg/kg) significantly reduced AST [PAST < 0.001, PAST < 0.001, PAST < 0.001, PAST < 0.001, respectively] and ALT [PALT = 0.117, PALT = 0.139, PALT = 0.189, PALT = 0.255, respectively] levels in hepatic fibrosis rats.